Cite
MLA Citation
Claudia M Denkinger et al.. “1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial.” Open forum infectious diseases, vol. 9, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100174898385.0x000003